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Exposure to excess arsenic, principally from
contaminated drinking water, is considered
one of the top environmental health threats
both in the United States and worldwide
[Abernathy et al. 2003; Mukherjee et al. 2006;
National Research Council (NRC) 1999,
2001; Smith et al. 2002; Watanabe et al.
2003]. The majority of this exposure is from
natural geological sources of As that contami-
nate groundwater. Epidemiologic studies have
linked chronic exposure to drinking-water As
with increased risks of various cancers, includ-
ing those of the lung, bladder, skin, and liver,
as well as numerous other noncancer illnesses
including vascular and cardiovascular disease,
diabetes, developmental and reproductive
problems, and neurologic and cognitive prob-
lems (Abernathy et al. 2003; NRC 1999,
2001; Smith et al. 2002; Tapio and Grosche
2006; Wasserman et al. 2004; Watanabe et al.
2003). Public water supplies in the United
States and Europe currently have a regulatory
limit of 10 ppb As (0.13 µM). However, a
large segment of the population in the United
States and worldwide obtains its drinking
water from private unregulated wells. Also,
many other areas of the world have higher
regulatory limits or water supplies that are
unregulated. Thus, As contamination contin-
ues to be a serious, ongoing public environ-
mental health problem affecting hundreds of
millions of people. 
There are a number of proposed mecha-
nisms for the ability of As to influence so
many diverse disease processes. These include
alterations in cell signaling, cell cycle control,
oxidative stress, DNA repair, and others
(Abernathy et al. 1999; Aposhian and
Aposhian 2006; Kitchin 2001; Rossman
2003). Moreover, it is becoming clear that
there are important dose-, time-, and tissue-
speciﬁc differences in effects of As, as well as
important gene–environment and co-exposure
interactions that complicate how As alters dis-
ease risk under any particular exposure circum-
stance (Andrew et al. 2003, 2006; Bodwell
et al. 2004, 2006; Karagas et al. 2004; Waalkes
et al. 2003). We previously reported that As is
a potent endocrine disruptor, altering steroid
hormone receptor (SR)-mediated gene regula-
tion at very low, environmentally relevant con-
centrations in cell culture and in whole-animal
models (Bodwell et al. 2004, 2006; Davey
et al. 2007; Kaltreider et al. 2001). We have
demonstrated that all five steroid receptors
(SRs) [i.e., the receptors for glucocorticoid
(GR), androgen (AR), progesterone (PR),
mineralocorticoid (MR), and estrogen (ER)
hormones] are affected in a similar manner,
suggesting a broad effect on these pathways
and also suggesting a common mechanism for
these effects (Bodwell et al. 2004, 2006; Davey
et al. 2007; Kaltreider et al. 2001). Given this
strong disruption on this entire class of
nuclear hormone receptors, we were interested
in whether these effects extend to other mem-
bers of the larger nuclear hormone receptor
superfamily. 
In this study we examined the effects of As
on gene regulation by two related class II
receptors, the retinoic acid (RA) receptor
(RAR) and the thyroid hormone (TH) recep-
tor (TR). Both receptors normally partner with
the retinoid X receptor (RXR) to form hetero-
dimers that act as transcription factors, binding
to the RA-response element (RARE) of RA-
inducible genes or the TH-responsive element
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BACKGROUND: Chronic exposure to excess arsenic in drinking water has been strongly associated
with increased risks of multiple cancers, diabetes, heart disease, and reproductive and developmen-
tal problems in humans. We previously demonstrated that As, a potent endocrine disruptor at low,
environmentally relevant levels, alters steroid signaling at the level of receptor-mediated gene regu-
lation for all ﬁve steroid receptors. 
OBJECTIVES: The goal of this study was to determine whether As can also disrupt gene regulation
via the retinoic acid (RA) receptor (RAR) and/or the thyroid hormone (TH) receptor (TR) and
whether these effects are similar to previously observed effects on steroid regulation. 
METHODS AND RESULTS: Human embryonic NT2 or rat pituitary GH3 cells were treated with
0.01–5 µM sodium arsenite for 24 hr, with or without RA or TH, respectively, to examine effects of
As on receptor-mediated gene transcription. At low, noncytotoxic doses, As significantly altered
RAR-dependent gene transcription of a transfected RAR response element–luciferase construct and
the native RA-inducible cytochrome P450 CYP26A gene in NT2 cells. Likewise, low-dose As signiﬁ-
cantly altered expression of a transfected TR response element–luciferase construct and the endoge-
nous TR-regulated type I deiodinase (DIO1) gene in a similar manner in GH3 cells. An amphibian
ex vivo tail metamorphosis assay was used to examine whether endocrine disruption by low-dose As
could have speciﬁc pathophysiologic consequences, because tail metamorphosis is tightly controlled
by TH through TR. TH-dependent tail shrinkage was inhibited in a dose-dependent manner by
0.1– 4.0 µM As. 
CONCLUSIONS: As had similar effects on RAR- and TR-mediated gene regulation as those previ-
ously observed for the steroid receptors, suggesting a common mechanism or action. Arsenic also
profoundly affected a TR-dependent developmental process in a model animal system at very low
concentrations. Because RAR and TH are critical for both normal human development and adult
function and their dysregulation is associated with many disease processes, disruption of these hor-
mone receptor–dependent processes by As is also potentially relevant to human developmental
problems and disease risk.
KEY WORDS: arsenic (As), CYP26A, deiodinase (DIO1), endocrine, retinoic acid (RA), steroid, thyroid
(TH). Environ Health Perspect 116:165–172 (2008). doi:10.1289/ehp.10131 available via
http://dx.doi.org/ [Online 26 October 2007](TRE) of TH-inducible genes, respectively
(Mark et al. 2006; Tsai and O’Malley 1994;
Wong and Shi 1995; Zhang and Lazar 2000).
We report here that As has signiﬁcant effects
on both RAR- and TR-mediated gene regula-
tion at very low doses (0.01–2 µM), and that
these effects are strikingly similar to those pre-
viously observed with the SRs, suggesting a
common mechanism. We also investigated
whether such As-induced alterations in hor-
mone signaling would lead to pathophysiologic
consequences, using amphibian tail meta-
morphosis as a model system. Anuran meta-
morphosis is highly dependent on TH- and
TR-mediated processes (Buchholz et al. 2006;
Buckbinder and Brown 1993; Wong and Shi
1995; Yaoita and Brown 1990) and is known
to be perturbed by agents that interfere with
TH or TR signaling (Buchholz et al. 2003;
Lim et al. 2002). Because TH is also important
for many aspects of mammalian embryonic
development (Galton 2005; Oppenheimer and
Samuels 1983; Porterfield and Hendrich
1993), this is a useful model for understanding
possible effects on human development.
Arsenic had profound effects on TH-mediated
ex vivo tail metamorphosis at very low, environ-
mentally relevant concentrations, suggesting
that there are likely to be other developmental
and pathophysiologic effects of low dose As
endocrine disruption in vivo. 
Methods
NT2 cell culture and transfections. NT2
[NTERA-2; American Type Culture Collec-
tion (ATCC), Manassas, VA] human embry-
onic carcinoma cells were maintained in
Dulbecco’s Modification of Eagle’s Medium
(DMEM; Invitrogen, Carlsbad, CA) plus
10% fetal bovine serum (FBS; Atlanta
Biologicals, Norcross, GA). Cells were split
into 6-well plates at 1.5 × 105 cells/well and
grown in phenol red–free DMEM plus 10%
charcoal-stripped FBS overnight for transfec-
tion experiments. The construct used was
generously provided by James DiRenzo
(Dartmouth Medical School). Brieﬂy, the con-
struct contains two canonical tandem RARE
sequences (5´-AGGTCA-(N)5-AGGTCA-3´)
upstream of a thymidine kinase promoter and
the firefly luciferase coding region with a
pBR322 backbone (RARE-LUC) (Kurokawa
et al. 1994). Cells were transfected with
250 ng of the RARE-LUC construct using
Fugene (Invitrogen) according to the manu-
facturer’s recommended protocol. All-trans-
retinoic acid (ATRA; Sigma Chemical Co.,
St. Louis, MO), reconstituted in DMSO and
stored at –20°C, was used as ligand at con-
centrations indicated. Arsenic (As, As+3,
sodium arsenite, NaAsO2; Sigma Chemical
Co.) was dissolved in water and kept frozen
until the day of use. Treatments were per-
formed 24 hr after transfection. ATRA and
As were added simultaneously at the doses
and for the durations described in “Results.”
Clonogenic cell survival assay for NT2
cells. NT2 cells were grown in phenol red–free
DMEM media plus 10% FBS and split into
6-well plates with approximately 100 cells/well
and allowed to grow overnight. Cells were
then exposed to 1.0–7.0 µM As plus 10 nM
ATRA for 24 hr. Next, fresh media without
As but including 10 nM ATRA was added,
and cell growth was checked daily. When
colonies of ≥ 25 cells were formed in control
wells, the media was removed and the cells
were ﬁxed in 1% formaldehyde for 1 hr and
then exposed to 100% methanol for 5 min.
Methanol was removed and cells were stained
with 0.3% Giemsa stain (in 70% methanol)
for 15 min. Colonies were rinsed twice with
phosphate-buffered saline (PBS) and counted.
Results are given as a percent of control, and
each condition was repeated in triplicate.
GH3 cell culture and transfections. GH3
rat pituitary tumor cells (ATCC) were cultured
in F-12 Nutrient Mixture (Ham) (Invitrogen)
supplemented with 15% horse serum (Atlanta
Biologicals) and 2.5% FBS. For triiodo-
thyronine (T3)/As treatments, 6-well plates
were seeded at 350,000–750,000 cells/well and
cultured in F-12 medium for 3 days. Cells
were then put into phenol red–free DMEM
supplemented with 10% charcoal-stripped
FBS for 18 hr prior to treatments. The TR
response element–luciferase (TRE-luc) con-
struct used for transfections was created by
exchanging the glucocorticoid response ele-
ment (GRE) sequence with two canonical
TRE direct repeats in the pXP2-GRE–
luciferase construct kindly contributed by
J. Bodwell (Dartmouth Medical School). The
ﬁnal construct was sequenced to verify success-
ful insertion. Transfections were performed
with Lipofectamine Plus (Invitrogen) with the
following optimizations. Twenty-four hours
after plating, media was changed to unsupple-
mented Opti-MEM (Invitrogen), then trans-
fection followed using the manufacturer’s
protocol. Three hours later, Opti-MEM was
replaced with phenol red–free DMEM plus
10% charcoal-stripped FBS for the duration of
the experiment. Cells were treated with As as
indicated. T3 (CAS 55-06-1; Sigma) was
reconstituted to 1 mM in 45% propylene
glycol (1,2-propanediol; Aldrich, St. Louis,
MO), 45% water, and 10% 0.1 N sodium
hydroxide and stored at 4°C covered.
Clonogenic cell survival assay for GH3
cells. Clonogenic assays were performed by
plating approximately 5,000 cells/well in a
6-well plate and allowing them to grow in
F-12 Nutrient Mixture for a total of 3–4 days.
After an 18-hr treatment in phenol red–free
DMEM with 10% charcoal-stripped serum,
cells were treated for 24 hr with various doses
of As, with or without T3. Arsenic was
removed and the cells were allowed to grow for
approximately 5 days in phenol red–free
DMEM plus 10% charcoal-stripped serum
with or without T3. Cells were trypsinized,
resuspended in PBS, and counted in azide-free
isotonic diluent (Valtech Diagnostics, Inc.,
Brackenridge, PA) using a Coulter Counter Z1
(Beckman Coulter, Fullerton, CA). Cells were
counted individually rather than via colony
formation (as with the NT2 cells) because
GH3 cells would not adhere under the condi-
tions necessary for staining the colonies.
ICP-MS analysis of total arsenic in cell
culture media. Total arsenic levels in cell cul-
ture media were measured by the Dartmouth
Superfund Trace Metal Core Facility using
collision cell inductively coupled plasma mass
spectroscopy (ICP-MS; Agilent octopole/reac-
tion cell 7500c ICP-MS; Agilent, Palo Alto,
CA), employing helium as the collision gas.
The media was diluted and analyzed by the
method of standard additions. Method detec-
tion limits were 0.005 µM, and the overall
method uncertainty was 8%. All media used
contained undetectable levels of As or levels
well below any of the exogenously added
effective doses (i.e., < 0.01 µM).
Luciferase and protein assays. Cells were
rinsed twice with cold PBS, covered with
150 µl of Promega lysis buffer, and scraped
from the plate. Cell lysates were frozen at
–80°C, thawed, vortexed for 30 sec, and spun
at 12,000 x g for 5 min; supernatants were
then transferred to a new tube and stored at
–80°C. Each experimental condition in each
experiment was done in replicates of six.
Transfection efﬁciency was consistent, with lit-
tle variability among the biological repeats in
each treatment group and low standard devia-
tions between 3 to 4 replicate experiments. We
used Prism software (GraphPad Software Inc.,
San Diego, CA) for all statistical analyses.
Luciferase assays were performed with the
Promega Luciferase Assay System kit (Promega,
Madison, WI) following the manufacturer’s
recommended protocol. We used a luminome-
ter (Dynatech Laboratories, Chantilly, VA) to
determine the light units per sample. Protein
assays were performed with the Pierce BCA
Protein Assay Reagent Kit (Pierce, Rockford,
IL) following manufacturer’s recommended
protocol to normalize the total level of pro-
tein in samples. Results of protein assays were
determined using a Thermomax microplate
reader (Molecular Devices, Sunnyvale, CA).
Semiquantitative real-time polymerase
chain reaction (PCR) for CYP26A or
DIO1. We isolated total RNA from the cells
after indicated treatment times using the
Qiashredder and RNeasy Mini Kits (Qiagen,
Valencia, CA) or Trizol (Invitrogen) according
to the manufacturer’s recommended protocols.
Contaminating genomic DNA was removed
using DNA-free kits (Ambion, Austin, TX),
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NanoDrop ND-1000 Spectrophotometer
(NanoDrop Technologies, Rockland, DE).
RNA (1–2 µg) was reverse-transcribed (gene-
specific primer) with Omniscript Reverse
Transcriptase (Qiagen), and primers were syn-
thesized to specifically amplify either the rat
type I deiodinase (DIO1) gene from the GH3
cells (GenBank accession no.BC083557;
National Library of Medicine 2007) or the
human cytochrome P450 26A (CYP26A) gene
from the NT2 cells (GenBank accession no.
NM000783) [see Supplemental Material
(http://www.ehponline.org/members/2007/
10131/suppl.pdf) for details]. We performed
semiquantitative real-time PCR (RT-PCR) to
assess relative quantities of each transcript with
the 7500 Real-Time PCR System (Applied
Biosystems, Foster City, CA). Negative con-
trols, including samples that would either
detect contaminating genomic DNA in the
RNA samples or contamination of PCR
reagents, were always included. On each plate
we included an internal standard curve for each
transcript, which consisted of a serial dilution
of cDNA known to contain the transcript in
question. The curve generated from the plate
was then used to quantify the level of tran-
script for all the experimental samples on the
same plate. RT-PCR for 18S levels was per-
formed to normalize total RNA levels. Results
were unaltered by 18S normalization.
Xenopus tadpole culture. We purchased
Xenopus laevis tadpoles from Nasco (Fort
Atkinson, WI). Animals were treated humanely
and with regard to alleviation of suffering; all
studies were performed in compliance with
institutional animal care and use guidelines
approved by Dartmouth Medical School
(Protocol 04-03-11). Animals were acclimated
to COMBO culture media (8.7 mg/L
K2HPO4, 36.9 mg/L MgSO4, 62.8 mg/L
NaNO3, 36.7 mg/L CaCl2, 28.42 mg/L
Na2SiO3, 24 mg/L H3BO4, 12.6 mg/L
NaHCO3 plus 2.18 µg/L H2SeO3, 16 µg/L
NaBr, 155 µg/L LiCl, 70 µg/L RbCl, 3.3 µg/L
KI, 150 µg/L SrCl2·6H2O, pH 7.7) and care-
fully staged when they arrived. Animals were
kept in COMBO media in 5-gal Nalgene
buckets (Nalge Nunc International, Rochester,
NY) at room temperature until they reached
stage 58 of development. Stage 58 was deter-
mined using staging criteria determined by
Nieuwkoop and Faber (1994). At stage 58,
Xenopus tadpoles have functional TR in tail tis-
sue, and the tail will metamorphose upon
exposure to T3 whether or not it is attached to
the animal (Shi et al. 2002; Tata 1966).
Ex-vivo tail culture. Tails were excised
from stage 58 tadpoles, dipped in 70%
ethanol, and immediately placed in a 6-well
plate with 3.0 mL phenol red–free minimal
essential media (MEM; Invitrogen) per well.
Arsenic was added to the media immediately
(doses indicated in the “Results”), and T3 was
added to the media 18 hr later. Trial experi-
ments in which arsenic and T3 were added
simultaneously resulted in similar shrinkage
patterns. Tail cultures were kept in the dark
at approximately 20–23°C. Medium was
changed daily, and photographs were taken
with a digital Nikon Coolpix camera (Nikon
Inc., Melville, NY). Experiments lasted
approximately 5 days. Fins of tails treated with
T3 only generally resorbed significantly or
completely in 4 days. Digital photographs were
analyzed with NIH Image software (National
Institutes of Health, Bethesda, MD) to assess
the area of tail fin each day. The area of the
dorsal tail ﬁn on day 4 was divided by the area
of the dorsal tail ﬁn on day 1 to determine the
percent of resorption. Each treatment group in
each experiment consisted of 6 tails, and the
experiment was repeated four to eight times.
Occasionally tails would not resorb at all when
given T3 alone, indicating that they did not
have sufficient TR to metamorphose, most
likely as a result of incorrect staging. In these
cases, all tails in the experiment that did not
resorb at all when given T3 were removed from
analysis regardless of treatment; 3%–10% of
the 42 tails in an experiment were removed
and they were evenly distributed between the
groups. Statistical signiﬁcance was determined
with Prism software using an unpaired t-test
and a p-value < 0.01 for the tail ﬁn area, except
when determining the optimal T3 dose where
the value shown is mean ± SE.
Results
Effects of As on RAR-mediated transcription.
Ligand-activated RAR forms heterodimers
with RXR and binds RAREs in RA-responsive
gene promoters, which induces transcription
(Mark et al. 2006). Initial dose–response
experiments (Figure 1B) demonstrated that
10 nM ATRA was an adequate and physiolog-
ically relevant dose of ligand that induces a
significant increase in expression of the
RARE-luc construct when transfected into
these cells. Cytotoxicity, measured by colony-
forming assays, demonstrated an LC50 (con-
centration lethal to 50%) of 3 µM for NT2
cells (Figure 1A). Very low concentrations of
As (0.05–0.25 µM) enhanced RA-inducible
RARE-luc expression compared with RA alone
(Figure 2). Conversely, a higher but still non-
cytotoxic concentration of 2.0 µM As strongly
repressed RAR-mediated induction of the con-
struct (as did the higher but slightly cytotoxic
Arsenic as an endocrine disruptor
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Figure 1. Dose–response curves for As, ATRA, and TH in NT2 and GH3 cells calculated using average
values for each dose. Data points represent the mean ± SE of data from three separate experiments.
(A) Cytotoxicity of As in NT2 cells exposed to As for 24 hr and assessed by colony-forming assay. Data are
expressed as colony formation as a percent of the control. (B) Induction of RARE-luc expression in NT2
cells by ATRA. RARE-luc expression is expressed as mean ± SE luciferase (LU) per gram protein. The
median effective concentration (EC50) for ATRA induction is approximately 7 nM. (C) Cytotoxicity of As in
GH3 cells assessed essentially as described for (A), except that cells were cultured in media plus stripped
serum with or without 10 nM T3. (D) Induction of DIO1 expression by T3 in GH3 cells assessed essentially
as described in (C), except that DIO1 mRNA was assessed by RT-PCR. Data are expressed as a percent of
the maximum value. See “Methods” for details.
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Without T3dose of 5 µM). The CYP26A gene is endoge-
nously expressed in NT2 cells, and a RARE in
its promoter facilitates its induction by ATRA
(Loudig et al. 2000). The transcript level of the
CYP26A gene was measured by RT-PCR in
NT2 cells after exposure to 10 nM ATRA plus
As (Figure 3). Similar to the RARE-luc con-
struct, hormone induction of CYP26A mRNA
expression was enhanced by 10 nM ATRA
plus As at a very low dose (0.01 µM), and its
induction was repressed in a dose-dependent
manner by As doses of ≥ 0.025 µM.
TH-mediated transcription. GH3 cells are
a rat pituitary tumor cell line that expresses
functional TRs and expresses genes directly
induced by TH. We performed a series of ini-
tial dose–response experiments to determine
an effective and physiologic dose of TH
(administered as T3) and found that 1–2 nM
T3 was sufficient to induce transcription
(Figure 1D) of the DIO1 gene approximately
4-fold. This was also sufﬁcient to induce the
TRE-luc construct 4-fold. GH3 cells, like the
NT2 cells, were moderately sensitive to the
toxic effects of As, with an LC50 of 5–10 µM,
as determined by a clonogenic cell survival
assay (Figure 1C). Interestingly, the clonogenic
assay results indicated an increase in prolifera-
tion rather than cytotoxicity when 0.1–1 µM
As was combined with T3 (the proliferative
effect was removed when T3 was removed).
The LC50 was decreased to 0.9–2.0 µM if the
cells were grown in stripped serum without T3.
The TRE-luc construct was repressed in a
dose-dependent manner by 0.5–2.0 µM As
(Figure 4). We then examined the effects of As
on TH induction of the endogenously
expressed DIO1 (Jakobs et al. 1997) by meas-
uring mRNA levels by RT-PCR 6 or 24 hr
after treatment. At 6 hr, concentrations of
0.01–2.0 µM As produced a biphasic dose
response similar to the NT2 results with RA,
with a signiﬁcant super-induction at lower As
concentrations (0.01–0.1 µM) and repression
at 2 µM (Figure 5A). The response at 24 hr
differed from the RAR-mediated genes in that
any repressive effects were gone, and 1.0 and
2.0 µM As enhanced hormone-stimulated
expression. Arsenic doses > 2 µM produced sig-
nificant cytotoxicity, so we could not deter-
mine whether As suppresses TH induction at
24 hr independent of general toxic mechanisms
that might compromise mRNA expression. 
TH-directed amphibian tail metamorpho-
sis. Based on the effects of As on TR-mediated
gene regulation described above, we were inter-
ested in whether there were specific patho-
physiologic consequences of this endocrine
disruption. We assessed T3-dependent tail
shrinkage by measuring the area of the tail ﬁn
over a 4-day period, which is generally the time
it takes for the ﬁn to completely resorb in our
assay. Fin resorption is the ﬁrst step in visible
tail metamorphosis, is amenable to quantita-
tion by morphometric analysis, and is repre-
sentative of the overall tail shrinkage process. A
10-nM dose of T3 in the tail culture media was
consistently sufﬁcient to induce tail ﬁn resorp-
tion (Figure 6); thus, we used this dose
throughout the subsequent experiments. As
shown in Figure 7, treatment of tails ex vivo
with T3 led to shrinkage of the tail fins that
was readily apparent. Control tail fins not
exposed to T3 or As normally shrank 10–20%
during an experiment (Figures 7 and 8). Tails
exposed to As alone shrank slightly less than
controls (Figure 8). In the As plus T3 groups,
the lowest As concentration used (0.05 µM)
had little effect compared with T3 alone, and
the tail fins resorbed approximately 58% in
both groups (Figures 7 and 8). However, con-
centrations of As above this (0.5–4 µM)
decreased T3-dependent tail ﬁn resorption in a
dose-dependent manner (Figure 8). A concen-
tration of 0.25 µM As slowed resorption by
4% compared with T3 alone, whereas 4 µM As
decreased resorption by 20%. Interestingly, the
intermediate concentration of 0.1 µM As did
not follow the dose-dependent pattern of the
higher As doses; this ﬁnding is discussed below.
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Figure 2. Effects of As on ATRA induction of RARE-
luc expression in NT2 cells. Cells were transfected
with the RARE-luc construct 24 hr before treatment
with 10 nM ATRA with or without simultaneous
treatment with As for 24 hr. See “Methods” for
details. Data are expressed as mean ± SE of the
values from replicates of experiments. Bars that do
not have the same letter are signiﬁcantly different
from each other at p < 0.003 using an unpaired t-test.
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Figure 3. Effects of As on ATRA induction of CYP26A
mRNA expression in NT2 cells. Cells were treated
with 10 nM ATRA with or without simultaneous
addition of As for 24 hr; mRNA expression was
measured by RT-PCR. See “Methods” for details.
Data are expressed as mean ± SE of the values
from replicates of experiments. Bars that do not
have the same letter are signiﬁcantly different from
each other at p < 0.003 using an unpaired t-test.
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Figure 4. Effects of As on T3 induction of TRE-luc
expression in GH3 cells. Cells were transfected
with the TRE-luc construct 24 hr before treatment
with 2 nM T3 with or without simultaneous treat-
ment with As for 24 hr. See “Methods” for details.
Data are expressed as mean ± SE of the values
from replicates of experiments. Bars that do not
have the same letter are signiﬁcantly different from
each other at p < 0.003 using an unpaired t-test. 
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Figure 5. Effects of As on T3 induction of DIO1 mRNA expression in GH3 cells. Cells were treated with 2 nM
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A BIn summary, As significantly altered the T3-
and TR-dependent metamorphosis of Xenopus
tails ex vivo, indicating that As disrupts T3 hor-
mone signaling through its receptor, TR/RXR,
and has the potential to affect hormone-
regulated embryonic development at low
physiologically and environmentally relevant
concentrations in vivo.
Discussion 
Based on our previous studies with SRs, we
were interested in whether As could also dis-
rupt other, less similar nuclear hormone recep-
tors. Because we were interested in examining
the effects of As on hormone regulation of
both transiently transfected gene constructs as
well as native hormone-responsive genes, we
chose two different cell culture models, each
optimal for the receptor system under study.
Our previous results (Davey et al. 2007), as
well as those of others (Kaltreider et al. 2001),
strongly indicate that working in the appropri-
ate cell line is critical to mimicking the effects
of As on gene expression observed in vivo.
Mann et al. (2005) reported that As had no
effect on ER-mediated gene expression in het-
erologous systems such as COS1 cells, which
do not normally express ER but require
co-transfection of an ER-expressing plasmid.
Lack of response in such systems, even when
the receptor is reexpressed, may indicate that
other critical aspects of the receptor machin-
ery (e.g., key coregulators that are critical for
the As response) may be missing. Also, the
sensitivity of cultured cells to the cytotoxic
effects of As is highly cell line speciﬁc; thus, it
is important to know the dose response to As
for a given cell line so the appropriate dose
range can be selected and the toxic-equivalent
doses between lines can be compared. In the
present study we found that NT2 cells are
more sensitive to the toxic effects of As than
other cell lines we have used. Also, in order to
examine the pathophysiologic consequences
of endocrine disruption of one of these type II
receptors by As, we chose another well-
characterized system, amphibian tail meta-
morphosis, which is known to be highly TR-
dependent (Brown et al. 1996; Das et al.
2006; Dodd and Dodd 1976; Lim et al.
2002; Veldhoen and Helbing 2001).
We observed significant effects of As at
very low, noncytotoxic, environmentally rele-
vant concentrations on both RAR- and TR-
mediated gene expression in this study. These
As effects were very similar to those previously
observed for GR and the other SRs, suggesting
a common mechanism of action. As with SRs,
the effects of As exhibited a complex dose–
response pattern that was biphasic, with As sig-
niﬁcantly enhancing hormone-mediated gene
expression at very low doses while strongly sup-
pressing gene expression at higher, but still
moderate, doses of As. Similar effects were
observed for GR, MR, PR, AR, and ER,
although the precise concentrations varied as a
function of relative As toxicity in each cell sys-
tem (Bodwell et al. 2004, 2006; Davey et al.
2007). Our previous studies with SRs strongly
suggest that the receptors themselves are not
the actual targets for these As effects. First, the
SRs share little absolute homology, yet they
respond almost identically to As (Bodwell et al.
2006; Davey et al. 2007). Although GR, MR,
AR, and PR share extensive similarity, ER is
much more distally related and shares little
absolute homology, but ER responds similarly
to As (Davey et al. 2007). Second, mutational
studies with GR indicated that neither the
N-terminal regulatory or C-terminal ligand-
binding domains were necessary to elicit the
effects of As (Bodwell et al. 2004, 2006).
Likewise, extensive mutational analysis of the
remaining central DNA-binding domain of
GR failed to demonstrate any critical region
that could serve as the likely target for As, nor
is there sufﬁcient homology among the SRs to
explain a common As effect. The present
results show similar effects of As on TR and
RAR in spite of their even greater divergence
from the SRs; this further supports the
hypothesis that it is some common aspect of
their regulation that is the actual target.
The mechanism of gene activation for TR
and RAR differs from that of the SRs. Unlike
the SRs, which form homodimers and bind to
palindromic hormone-responsive elements
(HREs) in promoters, TR and RAR each nor-
mally form obligate heterodimers with the
RXR to form a functional transcription factor.
The TR-RXRs and RAR-RXRs are also nor-
mally bound to their cognate response ele-
ments (TRE and RARE, respectively) in
hormone-responsive promoters in the absence
of ligand, unlike the SRs, which normally
reside as quiescent monomers in the cytoplasm
(GR, MR, PR, AR) or nucleus (ER) and then
migrate to their respective HREs following
hormone activation and dimerization.
Co-repressors normally prevent transactivation
of TR or RAR until ligand binding occurs
(Bastien and Rochette-Egly 2004; Hermanson
et al. 2002; McKenna and O’Malley 2002; Shi
et al. 2002). Similar to what was observed for
SRs, As produced a biphasic response to gene
Arsenic as an endocrine disruptor
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Figure 6. Effects of T3 on tail fin shrinkage of
Xenopus tadpole tails cultured ex vivo as described
in “Methods.” Data are expressed as mean ± SE of
values from six tails per treatment in three separate
experiments.
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Figure 7. Effects of As on T3-mediated tail shrinkage in Xenopus tadpole tails cultured ex vivo shown by
representive samples from tail resorption experiments. See “Methods” for details. Morphometric soft-
ware was used to trace the tail fin area (shown in black), which was used to calculate the differences
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Figure 8. Effects of As on T3-mediated tail shrink-
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are significantly different from each other at
p < 0.01 using pairwise Student’s t-test analysis.
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finduction with RAR and TR. The suppressive
effect of intermediate doses of As is seen uni-
versally and strongly with all of these nuclear
hormone receptors under virtually all experi-
mental conditions, and it appears to be most
closely tied to transcription. In contrast, the
low-dose As enhancement of hormone induc-
tion is more variable among receptors, is more
susceptible to experimental manipulation, and
appears to be most closely associated with ear-
lier steps of receptor activation, based on
detailed studies with GR (Bodwell et al. 2004,
2006). For example, certain GR mutants lack
the low-dose enhancement while retaining
intermediate dose suppression by As. Similarly,
the low-dose enhancement can be progressively
dampened and eventually lost by progressively
increasing the number of hormone-activated
receptors in the cell, although higher dose sup-
pression by As remains relatively constant
(Bodwell et al. 2004). We propose that the
mechanism by which As enhances hormone-
induced gene activation at very low doses is
distinct, and can be separated experimentally,
from the suppressive effects seen at the slightly
higher but still noncytotoxic intermediate
doses. However, the precise mechanisms by
which As elicits these two effects remains to be
determined. 
RAR mediates RA signaling during embry-
onic development. Either excessive or deﬁcient
levels of RA, a derivative of vitamin A, results
in teratogenic effects (Shenefelt 1972;
Thompson et al. 1964; Wolbach and Howe
1978). RA signaling is also involved in tissue
homeostasis, lipid metabolism, and cellular
differentiation and proliferation in the adult
(Shenefelt 1972). The family of retinaldehyde
dehydrogenases and Cyp26(A1,B1,C1) are
RA-synthesizing and RA-catabolizing
enzymes, respectively. Transgenic mice with-
out CYP26A1 result in embryonic lethal
phenotypes, thus indicating a key role of
CYP26A1 in embryogenesis (Abu-Abed et al.
2001). The present study indicates that RA-
dependent CYP26A1 mRNA expression can
be enhanced or repressed by As exposure,
depending on the dose of As. CYP26A1 plays
a key role in inactivating RA; therefore, its
dysregulation could have important patho-
physiogic consequences, including develop-
mental processes, similar to those of the
DIO1 gene (White et al. 1996, 1997).
Because these effects were observed for con-
centrations of As that are directly relevant to
environmental levels of As in drinking water
of concern throughout the United States and
many other parts of the world, this has
potentially important implications for human
reproduction and development in exposed
populations.
TR is the mediator of critical TH-regulated
processes in adults and during embryonic and
fetal development (Gothe et al. 1999). The
active form of TH, T3, is produced when
type I or type II deiodinase removes a speciﬁc
outer ring iodine of thyroxine (T4). T3 is the
active TH ligand that binds TR, and therefore
its production is a crucial step in TH-driven
gene induction. The DIO1 gene has a TRE in
its promoter and is directly induced by T3
through TR. The change in expression of
DIO1 we observed at 6 or 24 hr of As exposure
indicates a transient superinduction by As at
very low doses and a transient repression by As
at higher doses. Differential effects of acute ver-
sus chronic As exposure are of interest because
TH levels—kept in equilibrium by deiodinases
and T3 levels in the pituitary—are critical to
thyroid function in the whole body. Thus,
understanding how As alters T3 homeostasis
will be an important aspect of understanding
the overall effects of As on this hormone path-
way, both for human development and in
adult physiologic processes.
The clonogenic assays with the GH3 cells
indicated enhancement of proliferation at low-
dose As in the presence of T3. T3 activates
growth hormone in GH3 cells, causing prolif-
eration (Kitagawa et al. 1987; Kitamura et al.
2002), and low-dose arsenic has also been
shown to cause proliferation of cells (Hwang
et al. 2006; Vogt and Rossman 2001). Low-
dose As appears to enhance the proliferative
effect of T3, demonstrating another type of As-
induced endocrine disruption (i.e., enhance-
ment of proliferation that is hormone
dependent).
Metamorphosis of Xenopus laevis has been
extensively characterized (Buchholz et al. 2006;
Buckbinder and Brown 1993; Gudernatch
1912; Wong and Shi 1995; Yaoita and Brown
1990). In vivo, the tadpole produces T3 in con-
cert with induction of TR, leading to TH-
dependent alterations in gene expression that
regulate tail resorption (Brown et al. 1996; Das
et al. 2006; Dodd and Dodd 1976). This can
be mimicked by culturing appropriately staged
tadpole tails ex vivo and exposing them to
exogenous TH, leading to tail shrinkage similar
to that seen in vivo (Das et al. 2006; Lim et al.
2002; Tata 1966; Veldhoen and Helbing
2001). Tadpole tails will respond to T3 in the
culture media essentially as they would as part
of the whole animal, by shrinking through
what is thought to be a combination of apop-
tosis and necrosis (Du Pasquier et al. 2006;
Nakajima and Yaoita 2003). 
We assessed T3-dependent tail shrinkage
by measuring the area of the tail fin over a
4-day period, which is generally the time it
takes for the fin to completely resorb in our
assay. Fin resorption is the ﬁrst step in visible
tail metamorphosis, is amenable to quantita-
tion by morphometric analysis, and is repre-
sentative of the overall tail shrinkage process.
The ex vivo tail culture allows for the very con-
trolled and T3-driven metamorphosis of an
entire tissue and, because the tadpole skin is so
permeable, both T3 and As are able to diffuse
into the tissue from the media (Lim et al.
2002; Veldhoen and Helbing 2001). Tail
resorption is completely dependent on T3 act-
ing as a ligand for TR and trans-activating
genes necessary for resorption, as shown in
previous studies including those using an
antagonist to TR, which blocks these processes
(Lim et al. 2002). The lowest As concentra-
tion that had an effect on tail fin resorption
(0.1 µM) did not follow the dose-dependent
pattern of all the higher As concentrations.
(Figure 8). This biphasic pattern was highly
repeatable and statistically signiﬁcant, indicat-
ing two different dose responses over this
range and suggesting perhaps two different
mechanisms of action underlying these effects.
Indeed, two different mechanisms of interfer-
ence could lead to the same overt results (i.e.,
less ﬁn shrinkage).
Tail resorption is only one piece of the
complete transformation of the aquatic tad-
pole into the terrestrial frog (Das et al. 2006;
Dodd and Dodd 1976). Tissues in the animal
are completely remodeled to function on land.
In the space of a few weeks, body parts are
generated (limbs) while others completely
resorb (tail); cell death, growth, and differen-
tiation can occur simultaneously in a single
tissue (intestine, eye, blood, skin). All this
transformation is directed by TH. If TH is
removed, metamorphosis does not happen
and a continuously growing tadpole will result
(Allen 1916; Dodd and Dodd 1976). When
TR is expressed and T3 is produced, the pro-
gram for the transcription of genes necessary
for metamorphosis in any tissue is ready to
proceed. This model has relevance to human
development because the plasma levels of TH
spike in humans during the perinatal period
(6 months of gestation through several months
postnatal), which correlates temporally with
the TH spike in amphibians during meta-
morphosis (Shi et al. 2002). Extreme thyroid
deficiency in humans at birth leads to cre-
tinism, with characteristic mental retardation,
short stature, and hearing loss. These severe
deficiencies are detected at birth and can be
quickly treated with exogenous hormone, but
subtler effects may not be as evident at birth
(Galton 2005; Oppenheimer and Samuels
1983; Raz and Kelley 1997). Indeed, subtle
effects on cognitive function have been noted
in epidemiology studies of children exposed to
excess As in drinking water (Wasserman et al.
2004). Studies showing disruption of thyroid
hormone functions after As exposure in
rodents include an increase in thyroid cancer
(Yamamoto 1995), a synergistic effect between
As and TH on oxidative stress (Allen and Rana
2003), and a disregulation of deiodinase levels
in fetal brain with concurrent As exposure and
selenium depletion (Miyazaki et al. 2005).
Davey et al.
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strated that As can act as a potent endocrine
disruptor not only for the entire SR family
but also for two important members of the
larger nuclear hormone receptor superfamily.
It seems likely, based on the ubiquity of these
effects and their likely common or shared
mechanism(s), that As will also have similar
effects on other members of this large hor-
mone receptor superfamily. It will be impor-
tant to determine the extent to which this
occurs and under what conditions, but also to
investigate the biological consequences of
such effects. Including the present study, we
have demonstrated in two different in vivo
systems that there are speciﬁc and predictable
pathophysiologic effects of endocrine disrup-
tion by As. We previously reported that As
has profound effects on the GR-dependent
freshwater-to-saltwater transition of killifish
(Fundulus heteroclitus) (Shaw et al. 2007;
Stanton et al. 2006). 
Exposure to excess As in drinking water
has been associated with an extensive and
growing list of disease risks. Given the impor-
tant and myriad roles of hormones and their
receptors in normal physiology and in the
pathophysiology of these and other diseases, it
is likely that endocrine disruption by As plays
an important role. Previously, it was thought
that because As does not significantly accu-
mulate in the body, unlike persistent organics
or metals such as mercury and lead, and also
does not cause DNA damage or mutations, its
effects on disease risk might also be transient
and reversible. However, such effects of As on
hormone signaling at key developmental or
differentiation points might be expected to
result in long-term effects related to epi-
genetic phenomena such as imprinting. In
this regard, it is interesting to note several
recent studies that support this idea (Liu et al.
2006a; Shen et al. 2006; Waalkes et al.
2004a). Among other interesting changes, a
profound up-regulation of ER expression has
been reported in livers of adult mice exposed
in utero to As, in addition to their increased
incidence of liver tumors (Chen et al. 2004;
Liu et al. 2006b; Waalkes et al. 2004b). Two
recent epidemiology studies of humans
exposed to As in drinking water were also
provocative (Smith et al. 2006; Wasserman
et al. 2004). These studies suggest that there
can be signiﬁcant long-term consequences of
exposing young or developing individuals to
As during critical periods of development. We
propose that disruption of hormone signaling
is likely to be an important component of
these effects. Thus, understanding the role of
As as an endocrine disruptor will be impor-
tant for assessing the overall impact of As on
human health and in developing appropriate
risk assessment paradigms that are protective
of human health.
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